GMAB
Genmab A/S
There isn't enough reported data to score GMAB yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
GMAB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Strong |
GMAB's profitability and balance sheet are currently strong. There isn't enough data to rate its revenue and cash flow.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
GMAB PE Valuation
GMAB has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
GMAB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for GMAB, but weaker profitability. However, they disagree widely on these estimates.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
GMAB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | $12.16 | +85% |
| Q2 2024 | $6.59 | -12% |
| Q1 2024 | $6.85 | -9.9% |
| Q4 2023 | $6.59 | -14% |
| Q2 2023 | $7.48 | +81% |
| Q1 2023 | $7.60 | +101% |
| Q4 2022 | $7.66 | +95% |
| Q2 2022 | $4.14 | +48% |
GMAB has the stronger earnings trend. Trailing diluted EPS is up 63% for GMAB versus HIMS down 257%.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
GMAB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $2.1B | +17% |
| Q4 2024 | $1.8B | +27% |
| Q2 2024 | $115.8M | -81% |
| Q1 2024 | $89.6M | -79% |
| Q4 2023 | $1.4B | +1.2% |
| Q2 2023 | $619.6M | +32% |
| Q1 2023 | $421.2M | +34% |
| Q4 2022 | $1.4B | +89% |
HIMS has the stronger quarterly revenue trend. Revenue is up 49% for GMAB versus up 49% for HIMS.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 25% | -11 points |
| Q4 2024 | 36% | +0.4 points |
| Q2 2024 | 30% | +16 points |
| Q1 2024 | 19% | -30 points |
| Q4 2023 | 36% | -3.5 points |
| Q2 2023 | 35% | +11 points |
| Q1 2023 | 15% | -20 points |
| Q4 2022 | 49% | +9.4 points |
GMAB's operating margin was 25% last quarter, down 11 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
GMAB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $822M | +20% |
| Q4 2024 | $685.5M | +30% |
| Q2 2024 | $32M | -37% |
| Q1 2024 | $32M | -93% |
| Q4 2023 | $526.7M | +63% |
| Q2 2023 | $50.4M | -62% |
| Q1 2023 | $465.3M | +491% |
| Q4 2022 | $323.1M | +300% |
GMAB has the stronger cash trend. Its trailing FCF is up 218% versus its history, compared with HIMS at down 84%.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS still generates free cash flow, though less than at its 2024 peak: $8M over the past year.
GMAB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -7.7M shares |
| 1 year | -1.7% | -10.9M shares |
| 3 years | +4.5% | +27.9M shares |
| 5 years | +4.8% | +30M shares |
GMAB has 649M diluted shares, down 1.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q4 2024 | — |
| Q2 2024 | $65.1M |
| Q1 2024 | $11.7M |
| Q4 2023 | — |
| Q2 2023 | $5.2M |
| Q1 2023 | $92.4M |
| Q4 2022 | $94.8M |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over GMAB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
GMAB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2019 | -0.4x | Net Cash |
| Q1 2019 | -0.9x | Net Cash |
| Q4 2018 | -0.4x | Net Cash |
| Q3 2018 | -0.6x | Net Cash |
| Q2 2018 | -0.9x | Net Cash |
| Q1 2018 | -0.6x | Net Cash |
| Q4 2017 | -1.0x | Net Cash |
| Q3 2017 | -0.8x | Net Cash |
GMAB has more cash than debt.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
GMAB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 75.6 | Overbought |
| Stochastic | 81.0 | Overbought |
GMAB's weekly RSI is 76 (overbought) and its Stochastic is 81 (overbought).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
GMAB PE vs Healthcare Sector
| Metric | GMAB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
GMAB has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
GMAB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $43.8 | 18% above |
| 20 week MA | $36.3 | 43% above |
| 50 week MA | $31.8 | 63% above |
| 100 week MA | $27.7 | 87% above |
| 200 week MA | $29.7 | 74% above |
GMAB has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
GMAB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.3 | $39.1 | +76% |
| 2021 | $39.1 | $39.7 | +1.5% |
| 2022 | $39.7 | $43.1 | +8.5% |
| 2023 | $43.1 | $31.8 | -26% |
| 2024 | $31.8 | $21.0 | -34% |
| 2025 | $21.0 | $33.4 | +59% |
| 2026 YTD | $33.4 | $51.7 | +55% |
GMAB has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.